Elcelyx Therapeutics Inc is categorized under in San Diego, CA and active since 2009.
Elcelyx Therapeutics Inc was established in 2009, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Alain Baron, Chief Executive Officer at the company’s single location by writing to 11995 El Camino Real # 305, San Diego, California CA 92130 or by phoning (858) 344-2816. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Elcelyx Therapeutics Inc |
| Contact Person: | Alain Baron, Chief Executive Officer |
| Address: | 11995 El Camino Real # 305, San Diego, California 92130 |
| Phone Number: | (858) 344-2816 |
| Website Address: | elcelyx.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 4461100 |
| Share This Business: |
Elcelyx Therapeutics Inc was started in 2009 to provide professional under the SIC code 2834 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Alain Baron, Chief Executive Officer for inquiries that concern Elcelyx Therapeutics Inc by calling the company number (858) 344-2816, as your correspondence is most welcome. Additionally, the physical location of the single location of Elcelyx Therapeutics Inc can be found at the coordinates 32.935992,-117.23787 as well as the street address 11995 El Camino Real # 305 in San Diego, California 92130.
For its online presence, you may visit Elcelyx Therapeutics Inc’s website at elcelyx.com and engage with its social media outlets through on Twitter and on Facebook.